Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for poor sleep in tracheostomized ICU patients
ACTRN12610000008022Phase 4Recruiting
- Sponsor
- Alfred Health
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sleep disorder comparing Melatonin plus temazepam with Placebo plus temazepam (2 arms). Primary endpoint: Nocturnal total sleep time. Started Jun 2010; status: recruiting.
02
Drugs
melatonin
03
Conditions
sleep disorder
Beyond the preview
Go deeper on ACTRN12610000008022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000008022.